[1] 单光颂,王本臻, 李晶, 等. 以肺动脉高压为首发症状的先天性中枢性低通气综合征一例[J]. 亚洲儿科病例研究, 2019, 7(1):1-6. [2] 甄珍,袁越,高路,等.以"心脏扩大"为首诊的先天性中枢性低通气综合征一例[J].中国小儿急救医学,2020,27(12):957-958. [3] 李晓莺,郎玉洁,刘晨,等.先天性中枢性低通气综合征四例[J].中华新生儿科杂志,2018,33(4):262-265. [4] Weese-Mayer DE, Rand CM, Berry-Kravis EM, et al. Congenital central hypoventilation syndrome from past to future: model for translational and transitional autonomic medicine[J]. Pediatr Pulmonol, 2009, 44(6):521-535. [5] Paglietti MG,Cherchi C,Porcaro F,et al. Two novel mutations in exon 3 of PHOX2B gene: think about congenital central hypoventilation syndrome in patients with Hirschsprung disease[J].Ital J Pediatr,2019,45(1):49-52. [6] Kasi AS, Jurgensen TJ, Yen S, et al. Three-generation family with congenital central hypoventilation syndrome and novel PHOX2B gene non-polyalanine repeat mutation [J].J Clin Sleep Med,2017,13(7):925-927. [7] Cain JT, Kim DI, Quas M, et al.Nonsense pathogenic variants in exon 1 of PHOX2B lead to translational reinitiation in congenital central hypoventilation syndrome[J].Am J Med Genet A, 2017,173(5):1200-1207. [8] 张漪,彭斯聪,付佳敏,等.先天性中枢性低通气综合征五例[J].中华新生儿科杂志,2020,35(3):207-210. [9] Nobuta H,Cilio MR, Danhaive O, et al.Dysregulation of locus coeruleus development in congenital central hypoventilation syndrome[J].Acta Neuropathol,2015,130(2):171-183. [10] Schirwani S, Pysden K, Chetcuti P, et al. Carbamazepine improves apneic episodes in Congenital Central Hypoventilation Syndrome (CCHS) with a novel PHOX2B exon 1 missense mutation[J].J Clin Sleep Med,2017,13(11):1359-1362. [11] Souza RT,Campanharo FF, Araujo Júnior E, et al.Challenges in congenital central hypoventilation syndrome (Ondine's curse) on pregnancy:A case report[J].J Obstet Gynaecol,2017,37(1):107-108. [12] Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, et al. An official ATS clinical policy statement:Congenital central hypoventilation syndrome: genetic basis, diagnosis,and management[J].Am J Respir Crit Care Med, 2010,181(6):626-644. [13] MarionTL,Bradshaw WT.Congenital central hypoventilation syndrome and the PHOX2B gene mutation[J].Neonatal Netw,2011,30(6):397-401. [14] Szymońska I, Borgenvik TL,Karlsvik TM, et al. Novel mutationdeletion in the PHOX2B gene of the patient diagnosed with Neuroblastoma, Hirschsprung's Disease, and Congenital Central Hypoventilation Syndrome (NB-HSCR-CCHS) Cluster[J] .J Genet Syndr Gene Ther, 2015, 6(3):269-285. [15] Kasi AS, Kun SS, Keens TG,et al.Adult with PHOX2B mutation and late-onset congenital central hypoventilation syndrome[J].J Clin Sleep Med,2018,14(12):2079-2081. [16] Lombardo RC, Kramer E,Cnota JF, et al. Variable phenotype in a novel mutation in PHOX2B[J]. Am J Med Genet A,2017,173(6):1705-1709. [17] Katwa U, D'Gama AM, Qualls AE, et al. Atypical presentations associated with non-polyalanine repeat PHOX2B mutations[J].Am J Med Genet A,2018, 176(7):1627-1631. [18] Byers HM, Chen M, Gelfand AS, et al. Expanding the phenotype of congenital central hypoventilation syndrome impacts management decisions[J]. Am J Med Genet A, 2018, 176(6):1398-1404. [19] 许志飞. 先天性中枢性低通气综合征的诊断与治疗进展[J]. 中华实用儿科临床杂志, 2018, 33(4):273-276. [20] Weese-Mayer DE, Rand CM, Zhou A, et al. Congenital central hypoventilation syndrome: a bedside-to-bench success story for advancing early diagnosis and treatment and improved survival and quality of life[J]. Pediatr Res, 2017,81(1-2):192-201. [21] Patwari PP, Carroll MS, Rand CM, et al. Congenital central hypoventilation syndrome and the PHOX2B gene: a model of respiratory and autonomic dysregulation[J]. Respir Physiol Neurobiol, 2010, 173(3):322-335. [22] Tomycz ND, Haynes RL, Schmidt EF, et al. Novel neuropathologic findings in the Haddad syndrome[J]. Acta Neuropathol, 2010, 119(2):261-269. [23] Esteso Orduña B, Seijas Gómez R, García Esparza E,et al.Neuropsychological profile and social cognition in congenital central hypoventilation syndrome (CCHS):Correlation with neuroimaging in a clinical case[J]. J Clin Exp Neuropsychol, 2018, 40(1):75-83. [24] Kumar R, Woo MS,Macey PM, et al. Progressive gray matter changes in patients with congenital central hypoventilation syndrome[J]. Pediatr Res, 2012, 71(6):701-706. [25] Khan A,Sarnat HB, Spaetgens R. Congenital muscle fiber-type disproportion in a patient with congenital central hypoventilation syndrome due to PHOX2B mutations[J].J Child Neurol, 2008, 23(7):829-831. [26] Gourine AV, Kasymov V, Marina N, et al. Astrocytes control breathing through pH-dependent release of ATP[J]. Science, 2010, 329(5991):571-575. [27] Fu C,Xue R,Wang R,et al.Chemosensitive PHOX2B-expressing neurons are crucial for hypercapnic ventilatory response in the nucleus tractus solitaries[J].J Physiol,2017,595(14):4973-4989. [28] Patrone LG, Taxini CL, Biancardi V, et al. Neurochemical and electrical modulation of the locus coeruleus: contribution to CO2 drive to breathe[J]. Front Physiol, 2014, 5(288):1-13. [29] DiLascio S, Benfante R, Di Zanni E, et al. Structural and functional differences in PHOX2B frameshift mutations underlie isolated or syndromic congenital central hypoventilation syndrome[J].Hum Mutat, 2018,39(2):219-236. [30] Ye G,Han D, WangZ,et al. A novel c.676_677insG PHOX2B mutation in congenital central hypoventilation syndrome[J].J Clin Sleep Med, 2019,15(3):509-513. |